Tolvaptan Response Improves Overall Survival in Patients with Refractory Ascites: A Meta-Analysis | Zendy

Ioannis Bellos | Zendy; Konstantinos Kontzoglou | Zendy; Amanda Psyrri | Zendy; Vasilios Pergialiotis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tolvaptan Response Improves Overall Survival in Patients with Refractory Ascites: A Meta-Analysis

Author(s) -

Ioannis Bellos,

Konstantinos Kontzoglou,

Amanda Psyrri,

Vasilios Pergialiotis

Publication year - 2019

Publication title -

digestive diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.879

H-Index - 66

eISSN - 1421-9875

pISSN - 0257-2753

DOI - 10.1159/000503559

Subject(s) - medicine , ascites , tolvaptan , hazard ratio , gastroenterology , cirrhosis , subgroup analysis , hepatocellular carcinoma , meta analysis , refractory (planetary science) , cochrane library , confidence interval , hyponatremia , physics , astrobiology

Refractory ascites represents a significant complication of decompensated cirrhosis, associated with increased mortality rates. The aim of this meta-analysis was to evaluate whether response to treatment with tolvaptan is associated with improved overall survival in cirrhotic patients with refractory ascites.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research